Clinical Trials Logo

Clinical Trial Summary

A phase 3, multicenter, open-label, randomized, active-controlled study to evaluate the efficacy and safety of Desidustat Tablet versus Epoetin alfa Injection for the treatment of anemia in patients with CKD on dialysis. (DREAM-D)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04215120
Study type Interventional
Source Cadila Healthcare Limited
Contact
Status Completed
Phase Phase 3
Start date January 4, 2020
Completion date September 2, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT05270759 - Non-invasive Assessment to Predict Tolerance to Fluid Removal on Intermittent Kidney Replacement Therapy
Recruiting NCT04282616 - An Exercise Facilitator to Activate Simple Training Programs in the Dialysis Center N/A
Completed NCT05241652 - Inspiratory Muscle Training for Chronic Kidney Disease Patients on Hemodialysis N/A
Recruiting NCT04743947 - Vaccination Against COVID-19 in Chronic Kidney Disease